{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:27:06Z","timestamp":1783445226263,"version":"3.54.6"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"DOI":"10.1007\/s00381-026-07368-9","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:43:20Z","timestamp":1783439000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From developmental origins to relapse: molecular and therapeutic insights in medulloblastoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Noah","family":"Tourigny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5944-1810","authenticated-orcid":false,"given":"Carolina","family":"Fernandes da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-895X","authenticated-orcid":false,"given":"Vijay","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"7368_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","volume":"5","author":"PA Northcott","year":"2019","unstructured":"Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM (2019) Medulloblastoma Nat Rev Dis Primers 5:11","journal-title":"Medulloblastoma Nat Rev Dis Primers"},{"issue":"Suppl 10","key":"7368_CR2","doi-asserted-by":"publisher","first-page":"x1","DOI":"10.1093\/neuonc\/nou327","volume":"16","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, Stearns DS, Wolff JE, Wolinsky Y, Letterio JJ, Barnholtz-Sloan JS (2015) Alex\u2019s lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011. Neuro Oncol 16(Suppl 10):x1\u2013x36","journal-title":"Neuro Oncol"},{"key":"7368_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clon.2019.01.001","volume":"31","author":"L Padovani","year":"2019","unstructured":"Padovani L, Horan G, Ajithkumar T (2019) Radiotherapy advances in paediatric medulloblastoma treatment. Clin Oncol (R Coll Radiol) 31:171\u2013181","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"7368_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3171\/jns.1997.86.1.0013","volume":"86","author":"KM David","year":"1997","unstructured":"David KM, Casey ATH, Hayward RD, Harkness WFJ, Phipps K, Wade AM (1997) Medulloblastoma: is the 5-year survival rate improving? J Neurosurg 86:13\u201321","journal-title":"J Neurosurg"},{"issue":"7","key":"7368_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/jama.1948.72890240003006a","volume":"136","author":"HW Dargeon","year":"1948","unstructured":"Dargeon HW (1948) Cancer in children from birth to fourteen years of age. J Am Med Assoc 136:459","journal-title":"J Am Med Assoc"},{"key":"7368_CR6","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1200\/JCO.2017.72.7842","volume":"35","author":"V Ramaswamy","year":"2017","unstructured":"Ramaswamy V, Taylor MD (2017) Medulloblastoma: from myth to molecular. J Clin Oncol 35:2355\u20132363","journal-title":"J Clin Oncol"},{"key":"7368_CR7","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1097\/MPH.0000000000001095","volume":"40","author":"DL Johnston","year":"2018","unstructured":"Johnston DL, Keene D, Strother D, Taneva M, Lafay-Cousin L, Fryer C, Scheinemann K, Carret A-S, Fleming A, Afzal S, Wilson B, Bowes L, Zelcer S, Mpofu C, Silva M, Larouche V, Brossard J, Bouffet E (2018) Survival following tumor recurrence in children with medulloblastoma. J Pediatr Hematol Oncol 40:e159\u2013e163","journal-title":"J Pediatr Hematol Oncol"},{"key":"7368_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature11327","volume":"488","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Shih DJH, Peacock J, Garzia L, Sorana Morrissy A, Zichner T, St\u00fctz AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, Mack S, Dubuc A, Yao Y, Ramaswamy V, Luu B, Rolider A, Cavalli FMG, Wang X, Remke M, Wu X, Chiu RYB, Chu A, Chuah E, Corbett RD, Hoad GR, Jackman SD, Li Y, Lo A, Mungall KL, Ming Nip K, Qian JQ, Raymond AGJ, Thiessen N, Varhol RJ, Birol I, Moore RA, Mungall AJ, Holt R, Kawauchi D, Roussel MF, Kool M, Jones DTW, Witt H, Fernandez-L A, Kenney AM, Wechsler-Reya RJ, Dirks P, Aviv T, Grajkowska WA, Perek-Polnik M, Haberler CC, Delattre O, Reynaud SS, Doz FF, Pernet-Fattet SS, Cho B-K, Kim S-K, Wang K-C, Scheurlen W, Eberhart CG, F\u00e8vre-Montange M, Jouvet A, Pollack IF, Fan X, Muraszko KM, Yancey Gillespie G, Di Rocco C, Massimi L, Michiels EMC, Kloosterhof NK, French PJ, Kros JM, Olson JM, Ellenbogen RG, Zitterbart K, Kren L, Thompson RC, Cooper MK, Lach B, McLendon RE, Bigner DD, Fontebasso A, Albrecht S, Jabado N, Lindsey JC, Bailey S, Gupta N, Weiss WA, Bogn\u00e1r L, Klekner A, Van Meter TE, Kumabe T, Tominaga T, Elbabaa SK, Leonard JR, Rubin JB, Liau LM, Van Meir EG, Fouladi M, Nakamura H, Cinalli G, Garami M, Hauser P, Saad AG, Iolascon A, Jung S, Carlotti CG, Vibhakar R, Shin Ra Y, Robinson S, Zollo M, Faria CC, Chan JA, Levy ML, Sorensen PHB, Meyerson M, Pomeroy SL, Cho Y-J, Bader GD, Tabori U, Hawkins CE, Bouffet E, Scherer SW, Rutka JT, Malkin D, Clifford SC, Jones SJM, Korbel JO, Pfister SM, Marra MA, Taylor MD (2012) Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488:49\u201356","journal-title":"Nature"},{"key":"7368_CR9","doi-asserted-by":"publisher","first-page":"e3088","DOI":"10.1371\/journal.pone.0003088","volume":"3","author":"M Kool","year":"2008","unstructured":"Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, Van Sluis P, Troost D, Meeteren NS-V, Caron HN, Cloos J, Mr\u0161i\u0107 A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 3:e3088","journal-title":"PLoS ONE"},{"key":"7368_CR10","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1200\/JCO.2005.04.4974","volume":"24","author":"MC Thompson","year":"2006","unstructured":"Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ (2006) Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24:1924\u20131931","journal-title":"J Clin Oncol"},{"key":"7368_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251","journal-title":"Neuro Oncol"},{"key":"7368_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nature09587","volume":"468","author":"P Gibson","year":"2010","unstructured":"Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J, Finkelstein D, Pounds S, Weiss A, Patay Z, Scoggins M, Ogg R, Pei Y, Yang Z-J, Brun S, Lee Y, Zindy F, Lindsey JC, Taketo MM, Boop FA, Sanford RA, Gajjar A, Clifford SC, Roussel MF, McKinnon PJ, Gutmann DH, Ellison DW, Wechsler-Reya R, Gilbertson RJ (2010) Subtypes of medulloblastoma have distinct developmental origins. Nature 468:1095\u20131099","journal-title":"Nature"},{"key":"7368_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho B-K, Kim S-K, Wang K-C, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng H-K, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhak R, Hauser P, Van Veelen M-L, Kros JM, French PJ, Ra YS, Kumabe T, L\u00f3pez-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpe\u00f1a-Diazconti M, Chico Ponce De Le\u00f3n F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737-754.e736","journal-title":"Cancer Cell"},{"key":"7368_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3174\/ajnr.A3990","volume":"35","author":"S Perreault","year":"2014","unstructured":"Perreault S, Ramaswamy V, Achrol AS, Chao K, Liu TT, Shih D, Remke M, Schubert S, Bouffet E, Fisher PG, Partap S, Vogel H, Taylor MD, Cho YJ, Yeom KW (2014) MRI surrogates for molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 35:1263\u20131269","journal-title":"AJNR Am J Neuroradiol"},{"key":"7368_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3174\/ajnr.A5578","volume":"39","author":"D Mata-Mbemba","year":"2018","unstructured":"Mata-Mbemba D, Zapotocky M, Laughlin S, Taylor MD, Ramaswamy V, Raybaud C (2018) MRI characteristics of primary tumors and metastatic lesions in molecular subgroups of pediatric medulloblastoma: a single-center study. AJNR Am J Neuroradiol 39:949\u2013955","journal-title":"AJNR Am J Neuroradiol"},{"key":"7368_CR16","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41588-019-0531-7","volume":"51","author":"S Jessa","year":"2019","unstructured":"Jessa S, Blanchet-Cohen A, Krug B, Vladoiu M, Coutelier M, Faury D, Poreau B, De Jay N, H\u00e9bert S, Monlong J, Farmer WT, Donovan LK, Hu Y, McConechy MK, Cavalli FMG, Mikael LG, Ellezam B, Richer M, Allaire A, Weil AG, Atkinson J, Farmer J-P, Dudley RWR, Larouche V, Crevier L, Albrecht S, Filbin MG, Sartelet H, Lutz P-E, Nagy C, Turecki G, Costantino S, Dirks PB, Murai KK, Bourque G, Ragoussis J, Garzia L, Taylor MD, Jabado N, Kleinman CL (2019) Stalled developmental programs at the root of pediatric brain tumors. Nat Genet 51:1702\u20131713","journal-title":"Nat Genet"},{"key":"7368_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cancergen.2011.11.001","volume":"204","author":"V Ramaswamy","year":"2011","unstructured":"Ramaswamy V, Northcott PA, Taylor MD (2011) FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma. Cancer Genet 204:577\u2013588","journal-title":"Cancer Genet"},{"key":"7368_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gr\u00f6bner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz H-J, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, Waszak SM, Erkek S, Jones DTW, Worst BC, Kool M, Zapatka M, J\u00e4ger N, Chavez L, Hutter B, Bieg M, Paramasivam N, Heinold M, Gu Z, Ishaque N, J\u00e4ger-Schmidt C, Imbusch CD, Jugold A, H\u00fcbschmann D, Risch T, Amstislavskiy V, Gonzalez FGR, Weber UD, Wolf S, Robinson GW, Zhou X, Wu G, Finkelstein D, Liu Y, Cavalli FMG, Luu B, Ramaswamy V, Wu X, Koster J, Ryzhova M, Cho Y-J, Pomeroy SL, Herold-Mende C, Schuhmann M, Ebinger M, Liau LM, Mora J, McLendon RE, Jabado N, Kumabe T, Chuah E, Ma Y, Moore RA, Mungall AJ, Mungall KL, Thiessen N, Tse K, Wong T, Jones SJM, Witt O, Milde T, Von Deimling A, Capper D, Korshunov A, Yaspo M-L, Kriwacki R, Gajjar A, Zhang J, Beroukhim R, Fraenkel E, Korbel JO, Brors B, Schlesner M, Eils R, Marra MA, Pfister SM, Taylor MD, Lichter P (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547:311\u2013317","journal-title":"Nature"},{"key":"7368_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor MD, Northcott PA, Korshunov A, Remke M, Cho Y-J, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123:465\u2013472","journal-title":"Acta Neuropathol"},{"key":"7368_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","volume":"123","author":"M Kool","year":"2012","unstructured":"Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, Clifford SC, Pietsch T, von Bueren AO, Rutkowski S, McCabe M, Collins VP, Backlund ML, Haberler C, Bourdeaut F, Delattre O, Doz F, Ellison DW, Gilbertson RJ, Pomeroy SL, Taylor MD, Lichter P, Pfister SM (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123:473\u2013484","journal-title":"Acta Neuropathol"},{"key":"7368_CR21","doi-asserted-by":"crossref","unstructured":"Nobre L, Zapotocky M, Khan S, Fukuoka K, Fonseca A, McKeown T, Sumerauer D, Vicha A, Grajkowska WA, Trubicka J, Li KKW, Ng HK, Massimi L, Lee JY, Kim SK, Zelcer S, Vasiljevic A, Faure-Conter C, Hauser P, Lach B, van Veelen-Vincent ML, French PJ, Van Meir EG, Weiss WA, Gupta N, Pollack IF, Hamilton RL, Nageswara Rao AA, Giannini C, Rubin JB, Moore AS, Chambless LB, Vibhakar R, Ra YS, Massimino M, McLendon RE, Wheeler H, Zollo M, Ferruci V, Kumabe T, Faria CC, Sterba J, Jung S, L\u00f3pez-Aguilar E, Mora J, Carlotti CG, Olson JM, Leary S, Cain J, Krskova L, Zamecnik J, Hawkins CE, Tabori U, Huang A, Bartels U, Northcott PA, Taylor MD, Yip S, Hansford JR, Bouffet E, Ramaswamy V (2020) Pattern of relapse and treatment response in WNT-activated medulloblastoma. Cell Rep Med 1:100038","DOI":"10.1016\/j.xcrm.2020.100038"},{"key":"7368_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1200\/JCO.20.01372","volume":"39","author":"A Gajjar","year":"2021","unstructured":"Gajjar A, Robinson GW, Smith KS, Lin T, Merchant TE, Chintagumpala M, Mahajan A, Su J, Bouffet E, Bartels U, Schechter T, Hassall T, Robertson T, Nicholls W, Gururangan S, Schroeder K, Sullivan M, Wheeler G, Hansford JR, Kellie SJ, McCowage G, Cohn R, Fisher MJ, Krasin MJ, Stewart CF, Broniscer A, Buchhalter I, Tatevossian RG, Orr BA, Neale G, Klimo P Jr, Boop F, Srinivasan A, Pfister SM, Gilbertson RJ, Onar-Thomas A, Ellison DW, Northcott PA (2021) Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03). J Clin Oncol 39:822\u2013835","journal-title":"J Clin Oncol"},{"key":"7368_CR23","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00401-022-02505-5","volume":"144","author":"T Goschzik","year":"2022","unstructured":"Goschzik T, Mynarek M, Doerner E, Schenk A, Spier I, Warmuth-Metz M, Bison B, Obrecht D, Struve N, Kortmann RD, Schmid M, Aretz S, Rutkowski S, Pietsch T (2022) Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas. Acta Neuropathol 144:1143\u20131156","journal-title":"Acta Neuropathol"},{"key":"7368_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2008.07.003","volume":"14","author":"ZJ Yang","year":"2008","unstructured":"Yang ZJ, Ellis T, Markant SL, Read TA, Kessler JD, Bourboulas M, Schuller U, Machold R, Fishell G, Rowitch DH, Wainwright BJ, Wechsler-Reya RJ (2008) Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells. Cancer Cell 14:135\u2013145","journal-title":"Cancer Cell"},{"key":"7368_CR25","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1242\/dev.01793","volume":"132","author":"TG Oliver","year":"2005","unstructured":"Oliver TG, Read TA, Kessler JD, Mehmeti A, Wells JF, Huynh TT, Lin SM, Wechsler-Reya RJ (2005) Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development 132:2425\u20132439","journal-title":"Development"},{"key":"7368_CR26","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41586-022-05208-9","volume":"609","author":"KS Smith","year":"2022","unstructured":"Smith KS, Bihannic L, Gudenas BL, Haldipur P, Tao R, Gao Q, Li Y, Aldinger KA, Iskusnykh IY, Chizhikov VV, Scoggins M, Zhang S, Edwards A, Deng M, Glass IA, Overman LM, Millman J, Sjoboen AH, Hadley J, Golser J, Mankad K, Sheppard H, Onar-Thomas A, Gajjar A, Robinson GW, Hovestadt V, Orr BA, Patay Z, Millen KJ, Northcott PA (2022) Unified rhombic lip origins of group 3 and group 4 medulloblastoma. Nature 609:1012\u20131020","journal-title":"Nature"},{"key":"7368_CR27","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-016-1569-6","volume":"131","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, Robinson GW, Padovani L, Andr\u00e9 N, Massimino M, Pizer B, Packer R, Rutkowski S, Pfister SM, Taylor MD, Pomeroy SL (2016) Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 131:821\u2013831","journal-title":"Acta Neuropathol"},{"key":"7368_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, L\u00f3pez-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpe\u00f1a-Diazconti M, Ponce C, de Le\u00f3n F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737-754.e736","journal-title":"Cancer Cell"},{"key":"7368_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/neuonc\/nou357","volume":"18","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy V, Remke M, Adamski J, Bartels U, Tabori U, Wang X, Huang A, Hawkins C, Mabbott D, Laperriere N, Taylor MD, Bouffet E (2016) Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients? Neuro Oncol 18:291\u2013297","journal-title":"Neuro Oncol"},{"key":"7368_CR30","doi-asserted-by":"publisher","first-page":"e3088","DOI":"10.1371\/journal.pone.0003088","volume":"3","author":"M Kool","year":"2008","unstructured":"Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsic A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 3:e3088","journal-title":"PLoS ONE"},{"key":"7368_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1200\/JCO.19.00845","volume":"38","author":"L Lafay-Cousin","year":"2020","unstructured":"Lafay-Cousin L, Bouffet E, Strother D, Rudneva V, Hawkins C, Eberhart C, Horbinski C, Heier L, Souweidane M, Williams-Hughes C, Onar-Thomas A, Billups CA, Fouladi M, Northcott P, Robinson G, Gajjar A (2020) Phase II study of nonmetastatic desmoplastic medulloblastoma in children younger than 4 years of age: a report of the Children\u2019s Oncology Group (ACNS1221). J Clin Oncol 38:223\u2013231","journal-title":"J Clin Oncol"},{"key":"7368_CR32","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S1470-2045(18)30204-3","volume":"19","author":"GW Robinson","year":"2018","unstructured":"Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR, Hassall T, Indelicato DJ, Boop F, Klimo P, Sabin ND, Patay Z, Merchant TE, Stewart CF, Orr BA, Korbel JO, Jones DTW, Sharma T, Lichter P, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Sanders RP, Onar-Thomas A, Ellison DW, Gajjar A, Northcott PA (2018) Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. Lancet Oncol 19:768\u2013784","journal-title":"Lancet Oncol"},{"key":"7368_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41467-023-44300-0","volume":"15","author":"MP Gold","year":"2024","unstructured":"Gold MP, Ong W, Masteller AM, Ghasemi DR, Galindo JA, Park NR, Huynh NC, Donde A, Pister V, Saurez RA, Vladoiu MC, Hwang GH, Eisemann T, Donovan LK, Walker AD, Benetatos J, Dufour C, Garzia L, Segal RA, Wechsler-Reya RJ, Mesirov JP, Korshunov A, Pajtler KW, Pomeroy SL, Ayrault O, Davidson SM, Cotter JA, Taylor MD, Fraenkel E (2024) Developmental basis of SHH medulloblastoma heterogeneity. Nat Commun 15:270","journal-title":"Nat Commun"},{"key":"7368_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"7368_CR35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41586-022-05215-w","volume":"609","author":"LD Hendrikse","year":"2022","unstructured":"Hendrikse LD, Haldipur P, Saulnier O, Millman J, Sjoboen AH, Erickson AW, Ong W, Gordon V, Coudi\u00e8re-Morrison L, Mercier AL, Shokouhian M, Su\u00e1rez RA, Ly M, Borlase S, Scott DS, Vladoiu MC, Farooq H, Sirbu O, Nakashima T, Nambu S, Funakoshi Y, Bahcheli A, Diaz-Mejia JJ, Golser J, Bach K, Phuong-Bao T, Skowron P, Wang EY, Kumar SA, Balin P, Visvanathan A, Lee JJY, Ayoub R, Chen X, Chen X, Mungall KL, Luu B, B\u00e9rub\u00e9 P, Wang YC, Pfister SM, Kim S-K, Delattre O, Bourdeaut F, Doz F, Masliah-Planchon J, Grajkowska WA, Loukides J, Dirks P, F\u00e8vre-Montange M, Jouvet A, French PJ, Kros JM, Zitterbart K, Bailey SD, Eberhart CG, Rao AAN, Giannini C, Olson JM, Garami M, Hauser P, Phillips JJ, Ra YS, de Torres C, Mora J, Li KKW, Ng H-K, Poon WS, Pollack IF, L\u00f3pez-Aguilar E, Gillespie GY, Van Meter TE, Shofuda T, Vibhakar R, Thompson RC, Cooper MK, Rubin JB, Kumabe T, Jung S, Lach B, Iolascon A, Ferrucci V, de Antonellis P, Zollo M, Cinalli G, Robinson S, Stearns DS, Van Meir EG, Porrati P, Finocchiaro G, Massimino M, Carlotti CG, Faria CC, Roussel MF, Boop F, Chan JA, Aldinger KA, Razavi F, Silvestri E, McLendon RE, Thompson EM, Ansari M, Garre ML, Chico F, Egu\u00eda P, P\u00e9rezpe\u00f1a M, Morrissy AS, Cavalli FMG, Wu X, Daniels C, Rich JN, Jones SJM, Moore RA, Marra MA, Huang X, Reimand J, Sorensen PH, Wechsler-Reya RJ, Weiss WA, Pugh TJ, Garzia L, Kleinman CL, Stein LD, Jabado N, Malkin D, Ayrault O, Golden JA, Ellison DW, Doble B, Ramaswamy V, Werbowetski-Ogilvie TE, Suzuki H, Millen KJ, Taylor MD (2022) Failure of human rhombic lip differentiation underlies medulloblastoma formation. Nature 609:1021\u20131028","journal-title":"Nature"},{"key":"7368_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-021-02358-4","volume":"142","author":"H Coltin","year":"2021","unstructured":"Coltin H, Sundaresan L, Smith KS, Skowron P, Massimi L, Eberhart CG, Schreck KC, Gupta N, Weiss WA, Tirapelli D, Carlotti C, Li KKW, Ryzhova M, Golanov A, Zheludkova O, Absalyamova O, Okonechnikov K, Stichel D, von Deimling A, Giannini C, Raskin S, Van Meir EG, Chan JA, Fults D, Chambless LB, Kim SK, Vasiljevic A, Faure-Conter C, Vibhakar R, Jung S, Leary S, Mora J, McLendon RE, Pollack IF, Hauser P, Grajkowska WA, Rubin JB, van Veelen MC, French PJ, Kros JM, Liau LM, Pfister SM, Kool M, Kijima N, Taylor MD, Packer RJ, Northcott PA, Korshunov A, Ramaswamy V (2021) Subgroup and subtype-specific outcomes in adult medulloblastoma. Acta Neuropathol 142:859\u2013871","journal-title":"Acta Neuropathol"},{"key":"7368_CR37","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1001\/jamaoncol.2021.2224","volume":"7","author":"SES Leary","year":"2021","unstructured":"Leary SES, Packer RJ, Li Y, Billups CA, Smith KS, Jaju A, Heier L, Burger P, Walsh K, Han Y, Embry L, Hadley J, Kumar R, Michalski J, Hwang E, Gajjar A, Pollack IF, Fouladi M, Northcott PA, Olson JM (2021) Efficacy of carboplatin and isotretinoin in children with high-risk medulloblastoma: a randomized clinical trial from the Children\u2019s Oncology Group. JAMA Oncol 7:1313\u20131321","journal-title":"JAMA Oncol"},{"key":"7368_CR38","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1200\/JCO.20.02730","volume":"39","author":"JM Michalski","year":"2021","unstructured":"Michalski JM, Janss AJ, Vezina LG, Smith KS, Billups CA, Burger PC, Embry LM, Cullen PL, Hardy KK, Pomeroy SL, Bass JK, Perkins SM, Merchant TE, Colte PD, Fitzgerald TJ, Booth TN, Cherlow JM, Muraszko KM, Hadley J, Kumar R, Han Y, Tarbell NJ, Fouladi M, Pollack IF, Packer RJ, Li Y, Gajjar A, Northcott PA (2021) Children\u2019s oncology group phase III trial of reduced-dose and reduced-volume radiotherapy with chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 39:2685\u20132697","journal-title":"J Clin Oncol"},{"key":"7368_CR39","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1200\/JCO.2013.50.9539","volume":"32","author":"DJ Shih","year":"2014","unstructured":"Shih DJ, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM, Garzia L, Peacock J, Mack SC, Wu X, Rolider A, Morrissy AS, Cavalli FM, Jones DT, Zitterbart K, Faria CC, Sch\u00fcller U, Kren L, Kumabe T, Tominaga T, Shin Ra Y, Garami M, Hauser P, Chan JA, Robinson S, Bogn\u00e1r L, Klekner A, Saad AG, Liau LM, Albrecht S, Fontebasso A, Cinalli G, De Antonellis P, Zollo M, Cooper MK, Thompson RC, Bailey S, Lindsey JC, Di Rocco C, Massimi L, Michiels EM, Scherer SW, Phillips JJ, Gupta N, Fan X, Muraszko KM, Vibhakar R, Eberhart CG, Fouladi M, Lach B, Jung S, Wechsler-Reya RJ, F\u00e8vre-Montange M, Jouvet A, Jabado N, Pollack IF, Weiss WA, Lee JY, Cho BK, Kim SK, Wang KC, Leonard JR, Rubin JB, de Torres C, Lavarino C, Mora J, Cho YJ, Tabori U, Olson JM, Gajjar A, Packer RJ, Rutkowski S, Pomeroy SL, French PJ, Kloosterhof NK, Kros JM, Van Meir EG, Clifford SC, Bourdeaut F, Delattre O, Doz FF, Hawkins CE, Malkin D, Grajkowska WA, Perek-Polnik M, Bouffet E, Rutka JT, Pfister SM, Taylor MD (2014) Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol 32:886\u2013896","journal-title":"J Clin Oncol"},{"key":"7368_CR40","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S1470-2045(13)70449-2","volume":"14","author":"V Ramaswamy","year":"2013","unstructured":"Ramaswamy V, Remke M, Bouffet E, Faria CC, Perreault S, Cho YJ, Shih DJ, Luu B, Dubuc AM, Northcott PA, Sch\u00fcller U, Gururangan S, McLendon R, Bigner D, Fouladi M, Ligon KL, Pomeroy SL, Dunn S, Triscott J, Jabado N, Fontebasso A, Jones DT, Kool M, Karajannis MA, Gardner SL, Zagzag D, Nunes S, Pimentel J, Mora J, Lipp E, Walter AW, Ryzhova M, Zheludkova O, Kumirova E, Alshami J, Croul SE, Rutka JT, Hawkins C, Tabori U, Codispoti KE, Packer RJ, Pfister SM, Korshunov A, Taylor MD (2013) Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol 14:1200\u20131207","journal-title":"Lancet Oncol"},{"key":"7368_CR41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1200\/JCO.20.01359","volume":"39","author":"R Kumar","year":"2021","unstructured":"Kumar R, Smith KS, Deng M, Terhune C, Robinson GW, Orr BA, Liu APY, Lin T, Billups CA, Chintagumpala M, Bowers DC, Hassall TE, Hansford JR, Khuong-Quang DA, Crawford JR, Bendel AE, Gururangan S, Schroeder K, Bouffet E, Bartels U, Fisher MJ, Cohn R, Partap S, Kellie SJ, McCowage G, Paulino AC, Rutkowski S, Fleischhack G, Dhall G, Klesse LJ, Leary S, Nazarian J, Kool M, Wesseling P, Ryzhova M, Zheludkova O, Golanov AV, McLendon RE, Packer RJ, Dunham C, Hukin J, Fouladi M, Faria CC, Pimentel J, Walter AW, Jabado N, Cho YJ, Perreault S, Croul SE, Zapotocky M, Hawkins C, Tabori U, Taylor MD, Pfister SM, Klimo P Jr, Boop FA, Ellison DW, Merchant TE, Onar-Thomas A, Korshunov A, Jones DTW, Gajjar A, Ramaswamy V, Northcott PA (2021) Clinical outcomes and patient-matched molecular composition of relapsed medulloblastoma. J Clin Oncol 39:807\u2013821","journal-title":"J Clin Oncol"},{"key":"7368_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41586-019-1158-7","volume":"572","author":"MC Vladoiu","year":"2019","unstructured":"Vladoiu MC, El-Hamamy I, Donovan LK, Farooq H, Holgado BL, Sundaravadanam Y, Ramaswamy V, Hendrikse LD, Kumar S, Mack SC, Lee JJY, Fong V, Juraschka K, Przelicki D, Michealraj A, Skowron P, Luu B, Suzuki H, Morrissy AS, Cavalli FMG, Garzia L, Daniels C, Wu X, Qazi MA, Singh SK, Chan JA, Marra MA, Malkin D, Dirks P, Heisler L, Pugh T, Ng K, Notta F, Thompson EM, Kleinman CL, Joyner AL, Jabado N, Stein L, Taylor MD (2019) Childhood cerebellar tumours mirror conserved fetal transcriptional programs. Nature 572:67\u201373","journal-title":"Nature"},{"key":"7368_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41586-019-1434-6","volume":"572","author":"V Hovestadt","year":"2019","unstructured":"Hovestadt V, Smith KS, Bihannic L, Filbin MG, Shaw ML, Baumgartner A, DeWitt JC, Groves A, Mayr L, Weisman HR, Richman AR, Shore ME, Goumnerova L, Rosencrance C, Carter RA, Phoenix TN, Hadley JL, Tong Y, Houston J, Ashmun RA, DeCuypere M, Sharma T, Flasch D, Silkov A, Ligon KL, Pomeroy SL, Rivera MN, Rozenblatt-Rosen O, Rusert JM, Wechsler-Reya RJ, Li XN, Peyrl A, Gojo J, Kirchhofer D, Lotsch D, Czech T, Dorfer C, Haberler C, Geyeregger R, Halfmann A, Gawad C, Easton J, Pfister SM, Regev A, Gajjar A, Orr BA, Slavc I, Robinson GW, Bernstein BE, Suva ML, Northcott PA (2019) Resolving medulloblastoma cellular architecture by single-cell genomics. Nature 572:74\u201379","journal-title":"Nature"},{"key":"7368_CR44","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature13379","volume":"511","author":"PA Northcott","year":"2014","unstructured":"Northcott PA, Lee C, Zichner T, Stutz AM, Erkek S, Kawauchi D, Shih DJ, Hovestadt V, Zapatka M, Sturm D, Jones DT, Kool M, Remke M, Cavalli FM, Zuyderduyn S, Bader GD, VandenBerg S, Esparza LA, Ryzhova M, Wang W, Wittmann A, Stark S, Sieber L, Seker-Cin H, Linke L, Kratochwil F, Jager N, Buchhalter I, Imbusch CD, Zipprich G, Raeder B, Schmidt S, Diessl N, Wolf S, Wiemann S, Brors B, Lawerenz C, Eils J, Warnatz HJ, Risch T, Yaspo ML, Weber UD, Bartholomae CC, von Kalle C, Turanyi E, Hauser P, Sanden E, Darabi A, Siesjo P, Sterba J, Zitterbart K, Sumerauer D, van Sluis P, Versteeg R, Volckmann R, Koster J, Schuhmann MU, Ebinger M, Grimes HL, Robinson GW, Gajjar A, Mynarek M, von Hoff K, Rutkowski S, Pietsch T, Scheurlen W, Felsberg J, Reifenberger G, Kulozik AE, von Deimling A, Witt O, Eils R, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Korbel JO, Wechsler-Reya RJ, Pfister SM (2014) Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511:428\u2013434","journal-title":"Nature"},{"key":"7368_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00401-019-02020-0","volume":"138","author":"T Sharma","year":"2019","unstructured":"Sharma T, Schwalbe EC, Williamson D, Sill M, Hovestadt V, Mynarek M, Rutkowski S, Robinson GW, Gajjar A, Cavalli F, Ramaswamy V, Taylor MD, Lindsey JC, Hill RM, J\u00e4ger N, Korshunov A, Hicks D, Bailey S, Kool M, Chavez L, Northcott PA, Pfister SM, Clifford SC (2019) Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol 138:309\u2013326","journal-title":"Acta Neuropathol"},{"key":"7368_CR46","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s41586-025-08973-5","volume":"642","author":"K Okonechnikov","year":"2025","unstructured":"Okonechnikov K, Joshi P, Korber V, Rademacher A, Bortolomeazzi M, Mallm JP, Vaillant J, da Silva PBG, Statz B, Sepp M, Sarropoulos I, Yamada T, Wittmann A, Schramm K, Blattner-Johnson M, Fiesel P, Jones B, Jager N, Milde T, Pajtler KW, van Tilburg CM, Witt O, Bochennek K, Weber KJ, Nonnenmacher L, Reimann C, Ghasemi DR, Schuller U, Mynarek M, Rutkowski S, Jones DTW, Korshunov A, Rippe K, Westermann F, Thongjuea S, Hofer T, Kaessmann H, Kutscher LM, Pfister SM (2025) Oncogene aberrations drive medulloblastoma progression, not initiation. Nature 642:1062\u20131072","journal-title":"Nature"},{"key":"7368_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11060-020-03535-3","volume":"150","author":"D Bhattacharya","year":"2020","unstructured":"Bhattacharya D, Pomeroy SL, Pomeranz Krummel DA, Sengupta S (2020) Epigenetics and survivorship in pediatric brain tumor patients. J Neurooncol 150:77\u201383","journal-title":"J Neurooncol"},{"key":"7368_CR48","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-012-1077-2","volume":"125","author":"EC Schwalbe","year":"2013","unstructured":"Schwalbe EC, Williamson D, Lindsey JC, Hamilton D, Ryan SL, Megahed H, Garami M, Hauser P, Dembowska-Baginska B, Perek D, Northcott PA, Taylor MD, Taylor RE, Ellison DW, Bailey S, Clifford SC (2013) DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol 125:359\u2013371","journal-title":"Acta Neuropathol"},{"key":"7368_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature18004","volume":"534","author":"S Tu","year":"2016","unstructured":"Tu S, Narendra V, Yamaji M, Vidal SE, Rojas LA, Wang X, Kim SY, Garcia BA, Tuschl T, Stadtfeld M, Reinberg D (2016) Co-repressor CBFA2T2 regulates pluripotency and germline development. Nature 534:387\u2013390","journal-title":"Nature"},{"key":"7368_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-020-03591-9","volume":"150","author":"AR Haltom","year":"2020","unstructured":"Haltom AR, Toll SA, Cheng D, Maegawa S, Gopalakrishnan V, Khatua S (2020) Medulloblastoma epigenetics and the path to clinical innovation. J Neurooncol 150:35\u201346","journal-title":"J Neurooncol"},{"key":"7368_CR51","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature13268","volume":"510","author":"V Hovestadt","year":"2014","unstructured":"Hovestadt V, Jones DT, Picelli S, Wang W, Kool M, Northcott PA, Sultan M, Stachurski K, Ryzhova M, Warnatz HJ, Ralser M, Brun S, Bunt J, Jager N, Kleinheinz K, Erkek S, Weber UD, Bartholomae CC, von Kalle C, Lawerenz C, Eils J, Koster J, Versteeg R, Milde T, Witt O, Schmidt S, Wolf S, Pietsch T, Rutkowski S, Scheurlen W, Taylor MD, Brors B, Felsberg J, Reifenberger G, Borkhardt A, Lehrach H, Wechsler-Reya RJ, Eils R, Yaspo ML, Landgraf P, Korshunov A, Zapatka M, Radlwimmer B, Pfister SM, Lichter P (2014) Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature 510:537\u2013541","journal-title":"Nature"},{"key":"7368_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mcn.2017.09.003","volume":"87","author":"J Yi","year":"2018","unstructured":"Yi J, Wu J (2018) Epigenetic regulation in medulloblastoma. Mol Cell Neurosci 87:65\u201376","journal-title":"Mol Cell Neurosci"},{"key":"7368_CR53","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/nar\/gkm094","volume":"35","author":"S Pfister","year":"2007","unstructured":"Pfister S, Schlaeger C, Mendrzyk F, Wittmann A, Benner A, Kulozik A, Scheurlen W, Radlwimmer B, Lichter P (2007) Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res 35:e51","journal-title":"Nucleic Acids Res"},{"key":"7368_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-614","volume":"10","author":"MH Shahi","year":"2010","unstructured":"Shahi MH, Afzal M, Sinha S, Eberhart CG, Rey JA, Fan X, Castresana JS (2010) Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, cyclin D2, plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma. BMC Cancer 10:614","journal-title":"BMC Cancer"},{"key":"7368_CR55","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ccr.2014.02.004","volume":"25","author":"M Kool","year":"2014","unstructured":"Kool M, Jones DT, Jager N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, Stark S, Hutter S, Seker-Cin H, Johann P, Bender S, Schmidt C, Rausch T, Shih D, Reimand J, Sieber L, Wittmann A, Linke L, Witt H, Weber UD, Zapatka M, Konig R, Beroukhim R, Bergthold G, van Sluis P, Volckmann R, Koster J, Versteeg R, Schmidt S, Wolf S, Lawerenz C, Bartholomae CC, von Kalle C, Unterberg A, Herold-Mende C, Hofer S, Kulozik AE, von Deimling A, Scheurlen W, Felsberg J, Reifenberger G, Hasselblatt M, Crawford JR, Grant GA, Jabado N, Perry A, Cowdrey C, Croul S, Zadeh G, Korbel JO, Doz F, Delattre O, Bader GD, McCabe MG, Collins VP, Kieran MW, Cho YJ, Pomeroy SL, Witt O, Brors B, Taylor MD, Schuller U, Korshunov A, Eils R, Wechsler-Reya RJ, Lichter P, Pfister SM (2014) Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25:393\u2013405","journal-title":"Cancer Cell"},{"key":"7368_CR56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40478-024-01831-x","volume":"12","author":"F Tsiami","year":"2024","unstructured":"Tsiami F, Lago C, Pozza N, Piccioni F, Zhao X, L\u00fclsberg F, Root DE, Tiberi L, Kool M, Schittenhelm J, Bandopadhayay P, Segal RA, Tabatabai G, Merk DJ (2024) Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma. Acta Neuropathol Commun 12:125","journal-title":"Acta Neuropathol Commun"},{"key":"7368_CR57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/bpa.12019","volume":"23","author":"DT Jones","year":"2013","unstructured":"Jones DT, Northcott PA, Kool M, Pfister SM (2013) The role of chromatin remodeling in medulloblastoma. Brain Pathol 23:193\u2013199","journal-title":"Brain Pathol"},{"issue":"2302\u20132319","key":"7368_CR58","first-page":"e2312","volume":"59","author":"R Shiraishi","year":"2024","unstructured":"Shiraishi R, Cancila G, Kumegawa K, Torrejon J, Basili I, Bernardi F, Silva P, Wang W, Chapman O, Yang L, Jami M, Nishitani K, Arai Y, Xiao Z, Yu H, Lo Re V, Marsaud V, Talbot J, Lombard B, Loew D, Jingu M, Okonechnikov K, Sone M, Motohashi N, Aoki Y, Pfister SM, Chavez L, Hoshino M, Maruyama R, Ayrault O, Kawauchi D (2024) Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression. Dev Cell 59(2302\u20132319):e2312","journal-title":"Dev Cell"},{"key":"7368_CR59","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1200\/JCO.2014.60.1591","volume":"33","author":"GW Robinson","year":"2015","unstructured":"Robinson GW, Orr BA, Wu G, Gururangan S, Lin T, Qaddoumi I, Packer RJ, Goldman S, Prados MD, Desjardins A, Chintagumpala M, Takebe N, Kaste SC, Rusch M, Allen SJ, Onar-Thomas A, Stewart CF, Fouladi M, Boyett JM, Gilbertson RJ, Curran T, Ellison DW, Gajjar A (2015) Vismodegib exerts targeted efficacy against recurrent sonic hedgehog-subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032. J Clin Oncol 33:2646\u20132654","journal-title":"J Clin Oncol"},{"key":"7368_CR60","doi-asserted-by":"publisher","first-page":"102474","DOI":"10.1016\/j.xcrm.2025.102474","volume":"6","author":"X Chen","year":"2025","unstructured":"Chen X, Wang Z, Song Y, Su Y, Zhao Y, Li J, Wang W, Zhang J, Daniels C, Wu X, Saulnier O, Wang Y, Liu F, Deng K, Han D, Liu Z, Li M, Hendrikse LD, Rasnitsyn A, Wang EY, Wang D, Feng Z, Li Y, Zhao Z, Yuan H, Sun Y, Jiang Y, Shi Y, Yang T, Qi X, Hou Y, Li C, Liu YQ, Tian Y, Li S, Qiu X, Taylor MD, Li GL, Jiang T, Liu H (2025) Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer. Cell Rep Med 6:102474","journal-title":"Cell Rep Med"},{"key":"7368_CR61","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1038\/s41467-019-10307-9","volume":"10","author":"P Bandopadhayay","year":"2019","unstructured":"Bandopadhayay P, Piccioni F, O\u2019Rourke R, Ho P, Gonzalez EM, Buchan G, Qian K, Gionet G, Girard E, Coxon M, Rees MG, Brenan L, Dubois F, Shapira O, Greenwald NF, Pages M, Balboni Iniguez A, Paolella BR, Meng A, Sinai C, Roti G, Dharia NV, Creech A, Tanenbaum B, Khadka P, Tracy A, Tiv HL, Hong AL, Coy S, Rashid R, Lin JR, Cowley GS, Lam FC, Goodale A, Lee Y, Schoolcraft K, Vazquez F, Hahn WC, Tsherniak A, Bradner JE, Yaffe MB, Milde T, Pfister SM, Qi J, Schenone M, Carr SA, Ligon KL, Kieran MW, Santagata S, Olson JM, Gokhale PC, Jaffe JD, Root DE, Stegmaier K, Johannessen CM, Beroukhim R (2019) Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nat Commun 10:2400","journal-title":"Nat Commun"},{"key":"7368_CR62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nn.4190","volume":"19","author":"SC Mack","year":"2016","unstructured":"Mack SC, Hubert CG, Miller TE, Taylor MD, Rich JN (2016) An epigenetic gateway to brain tumor cell identity. Nat Neurosci 19:10\u201319","journal-title":"Nat Neurosci"},{"key":"7368_CR63","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146:904\u2013917","journal-title":"Cell"},{"key":"7368_CR64","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13046-022-02530-y","volume":"41","author":"MJ Kling","year":"2022","unstructured":"Kling MJ, Kesherwani V, Mishra NK, Alexander G, McIntyre EM, Ray S, Challagundla KB, Joshi SS, Coulter DW, Chaturvedi NK (2022) A novel dual epigenetic approach targeting BET proteins and HDACs in group 3 (MYC-driven) medulloblastoma. J Exp Clin Cancer Res 41:321","journal-title":"J Exp Clin Cancer Res"},{"key":"7368_CR65","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-13-2281","volume":"20","author":"P Bandopadhayay","year":"2014","unstructured":"Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, Cheshier SH, Qi J, Liu KW, Wechsler-Reya R, Weiss WA, Swartling FJ, Kieran MW, Bradner JE, Beroukhim R, Cho YJ (2014) BET bromodomain inhibition of MYC-amplified medulloblastoma. Clin Cancer Res 20:912\u2013925","journal-title":"Clin Cancer Res"},{"key":"7368_CR66","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1038\/s41467-024-47102-0","volume":"15","author":"NAM Shendy","year":"2024","unstructured":"Shendy NAM, Bikowitz M, Sigua LH, Zhang Y, Mercier A, Khashana Y, Nance S, Liu Q, Delahunty IM, Robinson S, Goel V, Rees MG, Ronan MA, Wang T, Kocak M, Roth JA, Wang Y, Freeman BB, Orr BA, Abraham BJ, Roussel MF, Schonbrunn E, Qi J, Durbin AD (2024) Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300\/CBP inhibition. Nat Commun 15:3483","journal-title":"Nat Commun"},{"key":"7368_CR67","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1093\/nar\/gkq184","volume":"38","author":"YF Ramos","year":"2010","unstructured":"Ramos YF, Hestand MS, Verlaan M, Krabbendam E, Ariyurek Y, van Galen M, van Dam H, van Ommen GJ, den Dunnen JT, Zantema A, t Hoen PA (2010) Genome-wide assessment of differential roles for p300 and CBP in transcription regulation. Nucleic Acids Res 38:5396\u20135408","journal-title":"Nucleic Acids Res"},{"key":"7368_CR68","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1016\/j.devcel.2025.06.016","volume":"60","author":"C N\u00f6r","year":"2025","unstructured":"N\u00f6r C, Kharas K, Rasnitsyn A, Vladoiu MC, Cho NW, Young JS, N\u00f6r F, Mankahla N, Haapasalo J, Nordfors K, Rapic S, Skowron P, Su\u00e1rez RA, Bahcheli AT, Ocsenas O, Chen X, Bahrampour S, Momin A, Sundaresan L, Ong W, Hendrikse LD, Abeysundara N, Juraschka K, Ly M, Pallota JG, Douglas T, Huang N, Wang H, Mak E, Qin L, Liu J, Shen L, Luu B, Manno A, Kumar SA, Donovan LK, Fong V, Richman C, Daniels C, Garzia L, Rich JN, Hawkins C, Wu X, DaCosta R, Reimand J, Huang X, Ramaswamy V, Raleigh DR, Taylor MD (2025) Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate immune process. Dev Cell 60:2880-2896.e2887","journal-title":"Dev Cell"},{"key":"7368_CR69","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1101\/gad.349538.122","volume":"36","author":"T Eisemann","year":"2022","unstructured":"Eisemann T, Wechsler-Reya RJ (2022) Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma. Genes Dev 36:514\u2013532","journal-title":"Genes Dev"},{"key":"7368_CR70","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41467-025-56268-0","volume":"16","author":"J Velz","year":"2025","unstructured":"Velz J, Freudenmann LK, Medici G, Dubbelaar M, Mohme M, Ghasemi DR, Scheid J, Kowalewski DJ, Patterson AB, Zeitlberger AM, Lamszus K, Westphal M, Eyrich M, Messing-Junger M, Rohrig A, Reinhard H, Beccaria K, Craveiro RB, Frey BM, Sill M, Nahnsen S, Gauder M, Kapolou K, Silginer M, Weiss T, Wirsching HG, Roth P, Grotzer M, Krayenbuhl N, Bozinov O, Regli L, Rammensee HG, Rushing EJ, Sahm F, Walz JS, Weller M, Neidert MC (2025) Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics. Nat Commun 16:1364","journal-title":"Nat Commun"},{"key":"7368_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner RC, Sterner RM (2021) CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J 11:69","journal-title":"Blood Cancer J"},{"key":"7368_CR72","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1158\/0008-5472.CAN-06-4309","volume":"67","author":"N Ahmed","year":"2007","unstructured":"Ahmed N, Ratnayake M, Savoldo B, Perlaky L, Dotti G, Wels WS, Bhattacharjee MB, Gilbertson RJ, Shine HD, Weiss HL, Rooney CM, Heslop HE, Gottschalk S (2007) Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res 67:5957\u20135964","journal-title":"Cancer Res"},{"key":"7368_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0340-z","volume":"6","author":"A Nellan","year":"2018","unstructured":"Nellan A, Rota C, Majzner R, Lester-McCully CM, Griesinger AM, Mulcahy Levy JM, Foreman NK, Warren KE, Lee DW (2018) Durable regression of medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells. J Immunother Cancer 6:30","journal-title":"J Immunother Cancer"},{"key":"7368_CR74","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1158\/1078-0432.CCR-23-1880","volume":"30","author":"R Ciccone","year":"2024","unstructured":"Ciccone R, Quintarelli C, Camera A, Pezzella M, Caruso S, Manni S, Ottaviani A, Guercio M, Del Bufalo F, Quadraccia MC, Orlando D, Di Cecca S, Sinibaldi M, Aurigemma M, Iaffaldano L, Sarcinelli A, D\u2019Amore ML, Ceccarelli M, Nazio F, Marabitti V, Giorda E, Pezzullo M, De Stefanis C, Carai A, Rossi S, Alaggio R, Del Baldo G, Becilli M, Mastronuzzi A, De Angelis B, Locatelli F (2024) GD2-targeting CAR T-cell therapy for patients with GD2+ medulloblastoma. Clin Cancer Res 30:2545\u20132557","journal-title":"Clin Cancer Res"},{"key":"7368_CR75","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-18-0432","volume":"25","author":"RG Majzner","year":"2019","unstructured":"Majzner RG, Theruvath JL, Nellan A, Heitzeneder S, Cui Y, Mount CW, Rietberg SP, Linde MH, Xu P, Rota C, Sotillo E, Labanieh L, Lee DW, Orentas RJ, Dimitrov DS, Zhu Z, Croix BS, Delaidelli A, Sekunova A, Bonvini E, Mitra SS, Quezado MM, Majeti R, Monje M, Sorensen PHB, Maris JM, Mackall CL (2019) CAR T cells targeting B7\u2013H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors. Clin Cancer Res 25:2560\u20132574","journal-title":"Clin Cancer Res"},{"key":"7368_CR76","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/neuonc\/noac236","volume":"25","author":"MY Schakelaar","year":"2023","unstructured":"Schakelaar MY, Monnikhof M, Crnko S, Pijnappel EW, Meeldijk J, Ten Broeke T, Bovenschen N (2023) Cellular immunotherapy for medulloblastoma. Neuro Oncol 25:617\u2013627","journal-title":"Neuro Oncol"},{"key":"7368_CR77","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","volume":"8","author":"RG Majzner","year":"2018","unstructured":"Majzner RG, Mackall CL (2018) Tumor antigen escape from CAR T-cell therapy. Cancer Discov 8:1219\u20131226","journal-title":"Cancer Discov"},{"key":"7368_CR78","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","volume":"22","author":"TJ Laskowski","year":"2022","unstructured":"Laskowski TJ, Biederst\u00e4dt A, Rezvani K (2022) Natural killer cells in antitumour adoptive cell immunotherapy. Nat Rev Cancer 22:557\u2013575","journal-title":"Nat Rev Cancer"},{"key":"7368_CR79","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11060-019-03091-5","volume":"142","author":"BA Kennis","year":"2019","unstructured":"Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan V (2019) Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI. J Neurooncol 142:395\u2013407","journal-title":"J Neurooncol"},{"key":"7368_CR80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2013.06.005","volume":"149","author":"D Liu","year":"2013","unstructured":"Liu D, Song L, Brawley VS, Robison N, Wei J, Gao X, Tian G, Margol A, Ahmed N, Asgharzadeh S, Metelitsa LS (2013) Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells. Clin Immunol 149:55\u201364","journal-title":"Clin Immunol"},{"key":"7368_CR81","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1093\/neuonc\/noaa047","volume":"22","author":"S Khatua","year":"2020","unstructured":"Khatua S, Cooper LJN, Sandberg DI, Ketonen L, Johnson JM, Rytting ME, Liu DD, Meador H, Trikha P, Nakkula RJ, Behbehani GK, Ragoonanan D, Gupta S, Kotrotsou A, Idris T, Shpall EJ, Rezvani K, Colen R, Zaky W, Lee DA, Gopalakrishnan V (2020) Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma. Neuro Oncol 22:1214\u20131225","journal-title":"Neuro Oncol"},{"key":"7368_CR82","doi-asserted-by":"publisher","first-page":"106043","DOI":"10.1016\/j.ebiom.2025.106043","volume":"122","author":"M Chen","year":"2025","unstructured":"Chen M, Shi X, Wang Y, Zhang J, Guo J, Guan X, Sun Y, Wu W, Li C, Tian Y, Ou Y, Li T, Jiang K, Taylor MD, Liao X, Zhang L, Sun T (2025) Profiling tumour-infiltrating immune cells in a large paediatric medulloblastoma cohort: a retrospective analysis. EBioMedicine 122:106043","journal-title":"EBioMedicine"},{"key":"7368_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.562315","author":"S Chen","year":"2021","unstructured":"Chen S, Zhang Z, Zheng X, Tao H, Zhang S, Ma J, Liu Z, Wang J, Qian Y, Cui P, Huang D, Huang Z, Wu Z, Hu Y (2021) Response efficacy of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.562315","journal-title":"Front Oncol"},{"key":"7368_CR84","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11060-018-2886-5","volume":"139","author":"K Hwang","year":"2018","unstructured":"Hwang K, Koh EJ, Choi EJ, Kang TH, Han JH, Choe G, Park SH, Yearley JH, Annamalai L, Blumenschein W, Sathe M, McClanahan T, Jung H, Wang KC, Kim SK, Kim CY (2018) PD-1\/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population. J Neurooncol 139:281\u2013291","journal-title":"J Neurooncol"},{"key":"7368_CR85","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3171\/2016.11.JNS16991","volume":"128","author":"D Murata","year":"2018","unstructured":"Murata D, Mineharu Y, Arakawa Y, Liu B, Tanji M, Yamaguchi M, Fujimoto K-i, Fukui N, Terada Y, Yokogawa R, Yamaguchi M, Minamiguchi S, Miyamoto S (2018) High programmed cell death 1 ligand\u20131 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma. J Neurosurg 128:710\u2013716","journal-title":"J Neurosurg"},{"key":"7368_CR86","doi-asserted-by":"publisher","first-page":"e1462430","DOI":"10.1080\/2162402X.2018.1462430","volume":"7","author":"M Bockmayr","year":"2018","unstructured":"Bockmayr M, Mohme M, Klauschen F, Winkler B, Budczies J, Rutkowski S, Sch\u00fcller U (2018) Subgroup-specific immune and stromal microenvironment in medulloblastoma. OncoImmunology 7:e1462430","journal-title":"OncoImmunology"},{"key":"7368_CR87","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/neuonc\/noad031","volume":"25","author":"IJ Dunkel","year":"2023","unstructured":"Dunkel IJ, Doz F, Foreman NK, Hargrave D, Lassaletta A, Andr\u00e9 N, Hansford JR, Hassall T, Eyrich M, Gururangan S, Bartels U, Gajjar A, Howell L, Warad D, Pacius M, Tam R, Wang Y, Zhu L, Cohen K (2023) Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908. Neuro Oncol 25:1530\u20131545","journal-title":"Neuro Oncol"},{"key":"7368_CR88","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1470-2045(19)30671-0","volume":"21","author":"B Geoerger","year":"2020","unstructured":"Geoerger B, Kang HJ, Yalon-Oren M, Marshall LV, Vezina C, Pappo A, Laetsch TW, Petrilli AS, Ebinger M, Toporski J, Glade-Bender J, Nicholls W, Fox E, DuBois SG, Macy ME, Cohn SL, Pathiraja K, Diede SJ, Ebbinghaus S, Pinto N (2020) Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1\u20132 trial. Lancet Oncol 21:121\u2013133","journal-title":"Lancet Oncol"},{"key":"7368_CR89","first-page":"vdaf099","volume":"7","author":"M Monnikhof","year":"2025","unstructured":"Monnikhof M, Schakelaar MY, Meulenbroeks C, Quist M, Perzolli A, Selten A, Koster CJM, Maassen DSC, Montoro Canelo A, Fredriks M, Koppers MJA, Clevers K, Klein J, Kaludjerovic V, Meeldijk J, Pijnappel EW, Rebel HG, van Kempen S, Crnko S, Koorman T, Federico A, Valzano F, Wesseling P, Calkoen FGJ, van der Lugt J, Ten Broeke T, Kool M, Bovenschen N (2025) Dual targeting of CD155\/TIGIT and PD-L1\/PD-1 immune checkpoints potentiates NK cell-mediated cytotoxicity in medulloblastoma. Neurooncol Adv 7:vdaf099","journal-title":"Neurooncol Adv"},{"key":"7368_CR90","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","volume":"20","author":"SZ Shalhout","year":"2023","unstructured":"Shalhout SZ, Miller DM, Emerick KS, Kaufman HL (2023) Therapy with oncolytic viruses: progress and challenges. Nat Rev Clin Oncol 20:160\u2013177","journal-title":"Nat Rev Clin Oncol"},{"key":"7368_CR91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/ITT.S198162","volume":"9","author":"TF Kabir","year":"2020","unstructured":"Kabir TF, Kunos CA, Villano JL, Chauhan A (2020) Immunotherapy for medulloblastoma: current perspectives. Immunotargets Ther 9:57\u201377","journal-title":"Immunotargets Ther"},{"key":"7368_CR92","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1158\/1078-0432.CCR-24-3721","volume":"31","author":"B Yu","year":"2025","unstructured":"Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S (2025) Measles oncolytic virus as an immunotherapy for recurrent\/refractory pediatric medulloblastoma and atypical teratoid\/rhabdoid tumor: results from PNOC005. Clin Cancer Res 31:3463\u20133475","journal-title":"Clin Cancer Res"},{"key":"7368_CR93","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/neuonc\/nov123","volume":"18","author":"GK Friedman","year":"2016","unstructured":"Friedman GK, Moore BP, Nan L, Kelly VM, Etminan T, Langford CP, Xu H, Han X, Markert JM, Beierle EA, Gillespie GY (2016) Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses. Neuro Oncol 18:227\u2013235","journal-title":"Neuro Oncol"},{"key":"7368_CR94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.omto.2023.07.006","volume":"30","author":"J Hedberg","year":"2023","unstructured":"Hedberg J, Studebaker A, Smith L, Chen C-Y, Westfall JJ, Cam M, Gross A, Hernandez-Aguirre I, Martin A, Kim D, Dhital R, Kim Y, Roberts RD, Cripe TP, Mardis ER, Cassady KA, Leonard J, Miller KE (2023) Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution. Mol Ther-Oncolytics 30:39\u201355","journal-title":"Mol Ther-Oncolytics"},{"key":"7368_CR95","doi-asserted-by":"crossref","unstructured":"Hedberg J, Studebaker A, Smith L, Chen C-Y, Westfall J, Cam M, Gross A, Roberts R, Cripe T, Mardis E, Cassady K, Leonard J, Miller K (2022) 1135 Single cell resolution of immune responses to oncolytic herpes simplex virus C134 in preclinical medulloblastoma models. J ImmunoTher Cancer 10(Suppl 2):A1179","DOI":"10.1136\/jitc-2022-SITC2022.1135"},{"key":"7368_CR96","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/jnen\/nly045","volume":"77","author":"EM Thompson","year":"2018","unstructured":"Thompson EM, Brown M, Dobrikova E, Ramaswamy V, Taylor MD, McLendon R, Sanks J, Chandramohan V, Bigner D, Gromeier M (2018) Poliovirus receptor (CD155) expression in pediatric brain tumors mediates oncolysis of medulloblastoma and pleomorphic xanthoastrocytoma. J Neuropathol Exp Neurol 77:696\u2013702","journal-title":"J Neuropathol Exp Neurol"},{"key":"7368_CR97","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1200\/JCO.22.02466","volume":"41","author":"H Coltin","year":"2023","unstructured":"Coltin H, Pequeno P, Liu N, Tsang DS, Gupta S, Taylor MD, Bouffet E, Nathan PC, Ramaswamy V (2023) The burden of surviving childhood medulloblastoma: a population-based, matched cohort study in Ontario, Canada. J Clin Oncol 41:2372\u20132381","journal-title":"J Clin Oncol"},{"key":"7368_CR98","first-page":"0","volume":"26","author":"GW Robinson","year":"2024","unstructured":"Robinson GW, Merchant TE, Orr BA, Bass JK, Conklin HM, Bag A, Dhanda SK, Pinto S, Delaney A, Mikkelsen M, Reddick W, Huang J, Ashford J, Edwards A, Christy LA, Soans E, Clarke M, Strother D, Fisher MJ, Bendel A, Hwang EI, Zhao S, Smith A, Gottardo NG, Hassall TEG, Elster J, Perreault S, Ramaswamy V, Partap S, Laughton S, Cohn R, Chintagumpala M, McCowage G, Sullivan M, Sayour E, Bowers D, Marks A, Lucas J, Tinkle C, Sabin ND, Klimo P, Ellison DW, Northcott PA, Onar-Thomas A, Gajjar A (2024) MDB-92. Effect of reduced-dose craniospinal irradiation and reduced-dose adjuvant chemotherapy on children and adolescents with WNT medulloblastoma without residual or metastatic disease: results from the SJMB12 clinical trial. Neuro Oncol 26:0\u20130","journal-title":"Neuro Oncol"},{"key":"7368_CR99","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1200\/JCO.2016.66.9077","volume":"34","author":"I Moxon-Emre","year":"2016","unstructured":"Moxon-Emre I, Taylor MD, Bouffet E, Hardy K, Campen CJ, Malkin D, Hawkins C, Laperriere N, Ramaswamy V, Bartels U, Scantlebury N, Janzen L, Law N, Walsh KS, Mabbott DJ (2016) Intellectual outcome in molecular subgroups of medulloblastoma. J Clin Oncol 34:4161\u20134170","journal-title":"J Clin Oncol"},{"key":"7368_CR100","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41568-025-00878-9","volume":"26","author":"MC Vozenin","year":"2026","unstructured":"Vozenin MC, Montay-Gruel P, Tsoutsou P, Limoli CL (2026) Mechanisms, challenges and opportunities for FLASH radiotherapy in cancer. Nat Rev Cancer 26:62\u201375","journal-title":"Nat Rev Cancer"},{"key":"7368_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216651","volume":"587","author":"R Tang","year":"2024","unstructured":"Tang R, Yin J, Liu Y, Xue J (2024) FLASH radiotherapy: a new milestone in the field of cancer radiotherapy. Cancer Lett 587:216651","journal-title":"Cancer Lett"},{"key":"7368_CR102","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/neuonc\/noac248","volume":"25","author":"BD Allen","year":"2023","unstructured":"Allen BD, Alaghband Y, Kramar EA, Ru N, Petit B, Grilj V, Petronek MS, Pulliam CF, Kim RY, Doan NL, Baulch JE, Wood MA, Bailat C, Spitz DR, Vozenin MC, Limoli CL (2023) Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy. Neuro Oncol 25:927\u2013939","journal-title":"Neuro Oncol"},{"key":"7368_CR103","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1667\/RADE-22-00021.1","volume":"198","author":"G Blain","year":"2022","unstructured":"Blain G, Vandenborre J, Villoing D, Fiegel V, Fois GR, Haddad F, Koumeir C, Maigne L, M\u00e9tivier V, Poirier F, Potiron V, Supiot S, Servagent N, Delpon G, Chiavassa S (2022) Proton irradiations at ultra-high dose rate vs. conventional dose rate: strong impact on hydrogen peroxide yield. Radiat Res 198:318\u2013324","journal-title":"Radiat Res"},{"key":"7368_CR104","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.ijrobp.2024.01.210","volume":"119","author":"L Portier","year":"2024","unstructured":"Portier L, Daira P, Fourmaux B, Heinrich S, Becerra M, Fouillade C, Berthault N, Dutreix M, Londo\u00f1o-Vallejo A, Verrelle P, Bernoud-Hubac N, Favaudon V (2024) Differential remodeling of the oxylipin pool after FLASH versus conventional dose-rate irradiation in vitro and in vivo. Int J Radiat Oncol Biol Phys 119:1481\u20131492","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7368_CR105","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ijrobp.2022.01.049","volume":"113","author":"A Perstin","year":"2022","unstructured":"Perstin A, Poirier Y, Sawant A, Tambasco M (2022) Quantifying the DNA-damaging effects of FLASH irradiation with plasmid DNA. Int J Radiat Oncol Biol Phys 113:437\u2013447","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7368_CR106","doi-asserted-by":"publisher","first-page":"110238","DOI":"10.1016\/j.radonc.2024.110238","volume":"196","author":"I Mart\u00ednez-Rovira","year":"2024","unstructured":"Mart\u00ednez-Rovira I, Montay-Gruel P, Petit B, Leavitt RJ, Gonz\u00e1lez-Vegas R, Froidevaux P, Juchaux M, Prezado Y, Yousef I, Vozenin MC (2024) Infrared microspectroscopy to elucidate the underlying biomolecular mechanisms of FLASH radiotherapy. Radiother Oncol 196:110238","journal-title":"Radiother Oncol"},{"key":"7368_CR107","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1158\/0008-5472.CAN-21-1500","volume":"81","author":"A Velalopoulou","year":"2021","unstructured":"Velalopoulou A, Karagounis IV, Cramer GM, Kim MM, Skoufos G, Goia D, Hagan S, Verginadis II, Shoniyozov K, Chiango J, Cerullo M, Varner K, Yao L, Qin L, Hatzigeorgiou AG, Minn AJ, Putt M, Lanza M, Assenmacher CA, Radaelli E, Huck J, Diffenderfer E, Dong L, Metz J, Koumenis C, Cengel KA, Maity A, Busch TM (2021) FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response. Cancer Res 81:4808\u20134821","journal-title":"Cancer Res"},{"key":"7368_CR108","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s43018-025-00905-6","volume":"6","author":"H Ni","year":"2025","unstructured":"Ni H, Reitman ZJ, Zou W, Akhtar MN, Paul R, Huang M, Zhang D, Zheng H, Zhang R, Ma R, Ngo G, Zhang L, Diffenderfer ES, Motlagh SAO, Kim MM, Minn AJ, Dorsey JF, Foster JB, Metz J, Koumenis C, Kirsch DG, Gong Y, Fan Y (2025) FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy. Nat Cancer 6:460\u2013473","journal-title":"Nat Cancer"},{"key":"7368_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-024-02419-4","author":"E Daugherty","year":"2024","unstructured":"Daugherty E, Zhang Y, Xiao Z, Mascia A, Sertorio M, Woo J, McCann C, Russell K, Sharma R, Khuntia D, Bradley J, Simone C, Breneman J, Perentesis J (2024) FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach. Radiat Oncol. https:\/\/doi.org\/10.1186\/s13014-024-02419-4","journal-title":"Radiat Oncol"},{"key":"7368_CR110","doi-asserted-by":"publisher","DOI":"10.1093\/neuped\/wuaf014","author":"J Schuemann","year":"2025","unstructured":"Schuemann J, Rothwell B, Mascia A, Fan Y, Loo BW, Yock T, Liu KX, Perentesis J, Haas-Kogan DA (2025) The potential and risks of FLASH radiotherapy in pediatric patients. Neuro-oncol Pediatr. https:\/\/doi.org\/10.1093\/neuped\/wuaf014","journal-title":"Neuro-oncol Pediatr"},{"key":"7368_CR111","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41571-022-00697-z","volume":"19","author":"MC Vozenin","year":"2022","unstructured":"Vozenin MC, Bourhis J, Durante M (2022) Towards clinical translation of FLASH radiotherapy. Nat Rev Clin Oncol 19:791\u2013803","journal-title":"Nat Rev Clin Oncol"},{"key":"7368_CR112","doi-asserted-by":"publisher","first-page":"102202","DOI":"10.1016\/j.xcrm.2025.102202","volume":"6","author":"A DeCarlo","year":"2025","unstructured":"DeCarlo A, MacLeod G, Fernandes da Silva C, Shen LQ, Povilaikaite J, Deane M, Aragao L, Sie M, Termini D, Magee J, Gudenas B, Sukumaran S, Charron F, Marcellus R, Al-Awar R, Aman A, Reynaud D, Trolat A, Wybenga-Groot L, Tabori U, N\u00f6r C, Harding SM, Moran MF, Northcott PA, Dirks P, Angers S, Ramaswamy V (2025) Targeting synthetic lethality between non-homologous end joining and radiation in very-high-risk medulloblastoma. Cell Rep Med 6:102202","journal-title":"Cell Rep Med"},{"key":"7368_CR113","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1093\/nar\/gkt522","volume":"41","author":"A Croset","year":"2013","unstructured":"Croset A, Cordeli\u00e8res FP, Berthault N, Buhler C, Sun J-S, Quanz M, Dutreix M (2013) Inhibition of DNA damage repair by artificial activation of PARP with siDNA. Nucleic Acids Res 41:7344\u20137355","journal-title":"Nucleic Acids Res"},{"key":"7368_CR114","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.1158\/1078-0432.CCR-20-1729","volume":"26","author":"S Ferreira","year":"2020","unstructured":"Ferreira S, Foray C, Gatto A, Larcher M, Heinrich S, Lupu M, Mispelter J, Boussin FD, Pouponnot C, Dutreix M (2020) AsiDNA is a radiosensitizer with no added toxicity in medulloblastoma pediatric models. Clin Cancer Res 26:5735\u20135746","journal-title":"Clin Cancer Res"},{"key":"7368_CR115","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/neuonc\/noab178","volume":"24","author":"S Richardson","year":"2022","unstructured":"Richardson S, Hill RM, Kui C, Lindsey JC, Grabovksa Y, Keeling C, Pease L, Bashton M, Crosier S, Vinci M, Andr\u00e9 N, Figarella-Branger D, Hansford JR, Lastowska M, Zakrzewski K, Jorgensen M, Pickles JC, Taylor MD, Pfister SM, Wharton SB, Pizer B, Michalski A, Joshi A, Jacques TS, Hicks D, Schwalbe EC, Williamson D, Ramaswamy V, Bailey S, Clifford SC (2022) Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse. Neuro Oncol 24:153\u2013165","journal-title":"Neuro Oncol"},{"key":"7368_CR116","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/bpa.12811","volume":"30","author":"R Van Ommeren","year":"2020","unstructured":"Van Ommeren R, Garzia L, Holgado BL, Ramaswamy V, Taylor MD (2020) The molecular biology of medulloblastoma metastasis. Brain Pathol 30:691\u2013702","journal-title":"Brain Pathol"},{"key":"7368_CR117","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3171\/2018.11.PEDS18506","volume":"23","author":"DW Fults","year":"2019","unstructured":"Fults DW, Taylor MD, Garzia L (2019) Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth. J Neurosurg Pediatr 23:613\u2013621","journal-title":"J Neurosurg Pediatr"},{"key":"7368_CR118","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature16478","volume":"529","author":"AS Morrissy","year":"2016","unstructured":"Morrissy AS, Garzia L, Shih DJH, Zuyderduyn S, Huang X, Skowron P, Remke M, Cavalli FMG, Ramaswamy V, Lindsay PE, Jelveh S, Donovan LK, Wang X, Luu B, Zayne K, Li Y, Mayoh C, Thiessen N, Mercier E, Mungall KL, Ma Y, Tse K, Zeng T, Shumansky K, Roth AJL, Shah S, Farooq H, Kijima N, Holgado BL, Lee JJY, Matan-Lithwick S, Liu J, Mack SC, Manno A, Michealraj KA, Nor C, Peacock J, Qin L, Reimand J, Rolider A, Thompson YY, Wu X, Pugh T, Ally A, Bilenky M, Butterfield YSN, Carlsen R, Cheng Y, Chuah E, Corbett RD, Dhalla N, He A, Lee D, Li HI, Long W, Mayo M, Plettner P, Qian JQ, Schein JE, Tam A, Wong T, Birol I, Zhao Y, Faria CC, Pimentel J, Nunes S, Shalaby T, Grotzer M, Pollack IF, Hamilton RL, Li X-N, Bendel AE, Fults DW, Walter AW, Kumabe T, Tominaga T, Collins VP, Cho Y-J, Hoffman C, Lyden D, Wisoff JH, Garvin JH, Stearns DS, Massimi L, Sch\u00fcller U, Sterba J, Zitterbart K, Puget S, Ayrault O, Dunn SE, Tirapelli DPC, Carlotti CG, Wheeler H, Hallahan AR, Ingram W, Macdonald TJ, Olson JJ, Van Meir EG, Lee J-Y, Wang K-C, Kim S-K, Cho B-K, Pietsch T, Fleischhack G, Tippelt S, Ra YS, Bailey S, Lindsey JC, Clifford SC, Eberhart CG, Cooper MK, Packer RJ, Massimino M, Garre ML, Bartels U, Tabori U, Hawkins CE, Dirks P, Bouffet E, Rutka JT, Wechsler-Reya RJ, Weiss WA, Collier LS, Dupuy AJ, Korshunov A, Jones DTW, Kool M, Northcott PA, Pfister SM, Largaespada DA, Mungall AJ, Moore RA, Jabado N, Bader GD, Jones SJM, Malkin D, Marra MA, Taylor MD (2016) Divergent clonal selection dominates medulloblastoma at recurrence. Nature 529:351\u2013357","journal-title":"Nature"},{"key":"7368_CR119","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-22-2108","volume":"82","author":"A Borgenvik","year":"2022","unstructured":"Borgenvik A, Holmberg KO, Bolin S, Zhao M, Savov V, Rosen G, Hutter S, Garancher A, Rahmanto AS, Bergstrom T, Olsen TK, Mainwaring OJ, Sattanino D, Verbaan AD, Rusert JM, Sundstrom A, Bravo MB, Dang Y, Wenz AS, Richardson S, Fotaki G, Hill RM, Dubuc AM, Kalushkova A, Remke M, Cancer M, Jernberg-Wiklund H, Giraud G, Chen X, Taylor MD, Sangfelt O, Clifford SC, Schuller U, Wechsler-Reya RJ, Weishaupt H, Swartling FJ (2022) Dormant SOX9-positive cells facilitate MYC-driven recurrence of medulloblastoma. Cancer Res 82:4586\u20134603","journal-title":"Cancer Res"},{"key":"7368_CR120","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s41467-024-54858-y","volume":"16","author":"K Desai","year":"2025","unstructured":"Desai K, Wanggou S, Luis E, Whetstone H, Yu C, Vanner RJ, Selvadurai HJ, Lee L, Vijay J, Jaramillo JE, Fan J, Guilhamon P, Kushida M, Li X, Stein G, Kesari S, Simons BD, Huang X, Dirks PB (2025) OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma. Nat Commun 16:1092","journal-title":"Nat Commun"},{"key":"7368_CR121","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccr.2014.05.005","volume":"26","author":"RJ Vanner","year":"2014","unstructured":"Vanner RJ, Remke M, Gallo M, Selvadurai HJ, Coutinho F, Lee L, Kushida M, Head R, Morrissy S, Zhu X, Aviv T, Voisin V, Clarke ID, Li Y, Mungall AJ, Moore RA, Ma Y, Jones SJ, Marra MA, Malkin D, Northcott PA, Kool M, Pfister SM, Bader G, Hochedlinger K, Korshunov A, Taylor MD, Dirks PB (2014) Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. Cancer Cell 26:33\u201347","journal-title":"Cancer Cell"},{"key":"7368_CR122","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41467-024-54861-3","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Lim C, Dismuke T, Malawsky DS, Oasa S, Bruce ZC, Offenhauser C, Baumgartner U, D\u2019Souza RCJ, Edwards SL, French JD, Ock LSH, Nair S, Sivakumaran H, Harris L, Tikunov AP, Hwang D, Alicea Pauneto CDM, Maybury M, Hassall T, Wainwright B, Kesari S, Stein G, Piper M, Johns TG, Sokolsky-Papkov M, Terenius L, Vukojevic V, McSwain LF, Gershon TR, Day BW (2025) Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179. Nat Commun 16:1091","journal-title":"Nat Commun"},{"key":"7368_CR123","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1200\/JCO.2000.18.16.3004","volume":"18","author":"PR Thomas","year":"2000","unstructured":"Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, Albright L, Allen JC, Packer RJ, Linggood R, Mulhern R, Stehbens JA, Langston J, Stanley P, Duffner P, Rorke L, Cherlow J, Friedman HS, Finlay JL, Vietti TJ, Kun LE (2000) Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18:3004\u20133011","journal-title":"J Clin Oncol"},{"key":"7368_CR124","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.cell.2018.01.038","volume":"172","author":"L Garzia","year":"2018","unstructured":"Garzia L, Kijima N, Morrissy AS, De Antonellis P, Guerreiro-Stucklin A, Holgado BL, Wu X, Wang X, Parsons M, Zayne K, Manno A, Kuzan-Fischer C, Nor C, Donovan LK, Liu J, Qin L, Garancher A, Liu KW, Mansouri S, Luu B, Thompson YY, Ramaswamy V, Peacock J, Farooq H, Skowron P, Shih DJH, Li A, Ensan S, Robbins CS, Cybulsky M, Mitra S, Ma Y, Moore R, Mungall A, Cho YJ, Weiss WA, Chan JA, Hawkins CE, Massimino M, Jabado N, Zapotocky M, Sumerauer D, Bouffet E, Dirks P, Tabori U, Sorensen PHB, Brastianos PK, Aldape K, Jones SJM, Marra MA, Woodgett JR, Wechsler-Reya RJ, Fults DW, Taylor MD (2018) A hematogenous route for medulloblastoma leptomeningeal metastases. Cell 172:1050\u20131062","journal-title":"Cell"},{"key":"7368_CR125","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/neuonc\/noac068","volume":"24","author":"N Qin","year":"2022","unstructured":"Qin N, Paisana E, Langini M, Picard D, Malzkorn B, Custodia C, Cascao R, Meyer FD, Blumel L, Gobbels S, Taban K, Bartl J, Bechmann N, Conrad C, Gravemeyer J, Becker JC, Stefanski A, Puget S, Barata JT, Stuhler K, Fischer U, Felsberg J, Ayrault O, Reifenberger G, Borkhardt A, Eisenhofer G, Faria CC, Remke M (2022) Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis. Neuro Oncol 24:1509\u20131523","journal-title":"Neuro Oncol"},{"key":"7368_CR126","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41556-025-01660-7","volume":"27","author":"N Abeysundara","year":"2025","unstructured":"Abeysundara N, Rasnitsyn A, Fong V, Bahcheli A, Van Ommeren R, Juraschka K, Vladoiu M, Ong W, Livingston B, de Antonellis P, Ly M, Holgado BL, Sirbu O, Bahrampour S, Min HK, Fan J, Nor C, Visvanathan A, Zhang J, Wang H, Qin L, Huang N, Pallotta J, Douglas T, Mak E, Su H, Ng K, Zhang KY, Daniels C, Lucas CG, Eberhart CG, Liu H, Jiang T, Notta F, Ramaswamy V, Reimand J, Gallo M, Rich JN, Wu X, Huang X, Taylor MD (2025) Metastatic medulloblastoma remodels the local leptomeningeal microenvironment to promote further metastatic colonization and growth. Nat Cell Biol 27:863\u2013874","journal-title":"Nat Cell Biol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-026-07368-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-026-07368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:04:12Z","timestamp":1783443852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-026-07368-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7368"],"URL":"https:\/\/doi.org\/10.1007\/s00381-026-07368-9","relation":{},"ISSN":["1433-0350"],"issn-type":[{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.\u00a0The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"288"}}